Unsupervised clustering revealed two atypical immune-activating Treg cell clusters common to both CBIA and RA patients, in which an immunoactivating (featuring ICOS+CD134+CD137+) cluster was distinct to CBIA patients. This evidence concerns the gene TNFRSF4 and rheumatoid arthritis.